Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ortega, Vanesa
SOLTI-2104, NCT05982093: Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer	Recruiting	2	48	Europe	Elacestrant, Orserdu, Triptorelin	SOLTI Breast Cancer Research Group	Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor, Premenopausal Breast Cancer	10/24	01/25